Provided by Tiger Fintech (Singapore) Pte. Ltd.

SciSparc Ltd.

0.3750
+0.03008.70%
Post-market: 0.3462-0.0288-7.68%19:52 EDT
Volume:358.19K
Turnover:129.95K
Market Cap:4.06M
PE:-0.07
High:0.3802
Open:0.3495
Low:0.3475
Close:0.3450
Loading ...

Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial

TipRanks
·
14 Mar

BRIEF-Scisparc, Clearmind apply for patent in South Korea for its co-developed treatment to overcome cocaine addiction

Reuters
·
10 Mar

Scisparc-Clearmind Collaboration Leads to Publication of Patent Application for Cocaine Addiction Psychedelic Combination Treatment in South Korea

THOMSON REUTERS
·
10 Mar

SciSparc-Clearmind Collaboration Leads to Publication of Patent Application for Cocaine Addiction Psychedelic Combination Treatment in South Korea

GlobeNewswire
·
10 Mar

Clearmind Medicine Announces Publication of Patent for Cocaine Addiction Psychedelic Combination Treatment in South Korea

GlobeNewswire
·
10 Mar

BRIEF-SciSparc Signs Definitive Agreement To Sell Mitocarex

Reuters
·
03 Mar

SciSparc signs definitive agreement to sell MitoCareX to N2OFF

TIPRANKS
·
03 Mar

Scisparc Signs Definitive Agreement to Sell Mitocarex, Computational Drug Discovery Company Targeting Resistant Cancers

THOMSON REUTERS
·
03 Mar

SciSparc Signs Definitive Agreement to Sell MitoCareX, Computational Drug Discovery Company Targeting Resistant Cancers

GlobeNewswire
·
03 Mar

Scisparc Ltd: on Feb 25, Co Entered Securities Purchase Agreements to Sell, Issue to Debentures in Aggregate Principal Amount of $4.2 Mln

THOMSON REUTERS
·
28 Feb

SciSparc extends $2M loan to support AutoMax growth

TIPRANKS
·
27 Feb

Scisparc Extends $2 Million Loan to Support Automax's Growth Following Automax’s Entry Into Direct Import of Jac Electric Vehicles

THOMSON REUTERS
·
27 Feb

SciSparc Extends $2 Million Loan to Support AutoMax's Growth Following AutoMax’s Entry into Direct Import of JAC Electric Vehicles

GlobeNewswire
·
27 Feb

N2OFF to Acquire Biotech Firm MitoCareX Bio; Shares Fall

MT Newswires Live
·
26 Feb

N2off Signs Definitive Agreement to Acquire Next-Gen Computational Drug Discovery Company, Targeting Hard to Treat Cancers

THOMSON REUTERS
·
26 Feb

N2OFF Signs Definitive Agreement to Acquire Next-Gen Computational Drug Discovery Company, Targeting Hard To Treat Cancers

GlobeNewswire
·
26 Feb